John D. Hogoboom is the vice chair of the Life Sciences practice at Lowenstein Sandler. His practice focuses on the middle market, structuring public and private investments in drug discovery companies for investment banking and investor clients, as well as negotiating cross-border M&A transactions for industrial companies. He has represented underwriters in numerous public offerings, divestitures of businesses, and lead investors in private offerings. He is listed in both the corporate law and securities law categories in The Best Lawyers in America since 2007 and a Martindale-Hubbell Top Technology Lawyer. He is widely quoted in various publications, an author of numerous articles, and a frequent speaker on topics regarding the SEC, JOBS Act and various Specialty Finance issues.